Wells Fargo’s Accretive Health AH Stock Holding History

Wells Fargo’s Portfolio AH Stock Details AH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-2,000	Closed	-$16K	–	6576
2014 Q1	$16K	Hold	2,000	–	–	﹤0.01%	5289
2013 Q4	$18K	Buy	2,000 +500	+33%	+$4.3K	﹤0.01%	5053
2013 Q3	$14K	Sell	1,500 -253,401	-99%	-$2.52M	﹤0.01%	5060
2013 Q2	$2.75M	Buy	+254,901	New	+$2.68M	﹤0.01%	2569

Other funds holding AH

JRP

Jasper Ridge Partners Menlo Park, California $4.69B AUM 31.34% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

RMC

Regis Management Company Menlo Park, California $331M AUM 14.13% 1-Year Est. Return

BCM

Breithorn Capital Management New York $141M AUM 41.82% 1-Year Est. Return

ECM

EII Capital Management New York $774K AUM 22.41% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

MIM

Merion Investment Management Bay Harbor Islands, Florida $1.26M AUM 28.57% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

SCM

Stonebridge Capital Management Los Angeles, California $208M AUM

Wells Fargo's AH Position: Q2 2014 in Review

Wells Fargo sold out of Accretive Health (AH) in Q2 2014, closing a stake of 2,000 shares — an estimated $16K sold.

Wells Fargo first reported a position in AH in Q2 2013 and held it in 4 quarters. The position peaked at $2.75M in Q2 2013. 12 funds tracked by Wall St. Rank hold AH as of Q2 2014.

Wells Fargo reported no remaining Accretive Health position as of Q2 2014 after selling out during the quarter.
Wells Fargo sold 2,000 Accretive Health shares in Q2 2014, an estimated $16K.
Wells Fargo first reported a position in Accretive Health in Q2 2013 and held it in 4 quarters.
Wells Fargo's Accretive Health position peaked at $2.75M in Q2 2013.
12 funds tracked by Wall St. Rank held Accretive Health as of Q2 2014.

Based on Wells Fargo's 13F filing for Q2 2014, filed 12 Aug 2014.